A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients

References

• Brindley DN. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer. J Cell Biochem. 2004;92(5):900–912. PubMed: 15258914.
   PubMed Web of Science ®Google Scholar
• Drzazga A, Sowińska A, Koziołkiewicz M. Lysophosphatidylcholine and lysophosphatidylinosiol–novel promissing signaling molecules and their possible therapeutic activity. Acta Pol Pharm. 2014;71(6): 887–899. PubMed: 25745761.
   PubMed Web of Science ®Google Scholar
• Gomez-Muñoz A. The role of ceramide 1-phosphate in tumor cell survival and dissemination. Adv Cancer Res. 2018;140: 217–234. PubMed: 30060810.
   PubMed Web of Science ®Google Scholar
• Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732–749. PubMed: 27658529.
   PubMed Web of Science ®Google Scholar
• Dharwadkar P, Greenan G, Singal AG, et al. Is colorectal cancer in patients younger than 50 years of age the same disease as in older patients? Clin Gastroenterol Hepatol. 2019;3(19):1181–1184. PubMed: 31669054.
   Google Scholar
• Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–2185. PubMed:31488504.
   PubMed Web of Science ®Google Scholar
• Aguirre-Portolés C, Fernández LP, Ramírez de Molina A. Precision nutrition for targeting lipid metabolism in colorectal cancer. Nutrients. 2017;9(10):1076. PubMed: 28956850.
   PubMed Web of Science ®Google Scholar
• Liu T, Peng F, Yu J, et al. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression. Anal Bioanal Chem. 2019;411(20):5079–5088. PubMed: 31201454.
   PubMed Web of Science ®Google Scholar
• Pakiet A, Kobiela J, Stepnowski P, et al. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis. 2019;18(1):29. PubMed: 30684960.
   PubMed Web of Science ®Google Scholar
• Li F, Qin X, Chen H, et al. Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom. 2013;27(1):24–34. PubMed: 23239314.
   PubMed Web of Science ®Google Scholar
• Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10(11):766. PubMed: 25432777.
   PubMed Web of Science ®Google Scholar
• Butler LM, Yuan JM, Huang JY, et al. Plasma fatty acids and risk of colon and rectal cancers in the Singapore Chinese health study. NPJ Precis Oncol. 2017;1(1):38. PubMed: 29872717.
   PubMedGoogle Scholar
• Mika A, Kobiela J, Czumaj A, et al. Hyper-elongation in colorectal cancer tissue - cerotic acid is a potential novel serum metabolic marker of colorectal malignancies. Cell Physiol Biochem. 2017;41(2):722–730. PubMed: 28214830.
   PubMedGoogle Scholar
• Giuliani A, Ferrara F, Scimò M, et al. Adipose tissue fatty acid composition and colon cancer: a case-control study. Eur J Nutr. 2014;53(4):1029–1037. PubMed: 24178365.
   PubMed Web of Science ®Google Scholar
• Jurowski K, Kochan K, Walczak J, et al. Analytical Techniques in Lipidomics: state of the Art. Crit Rev Anal Chem. 2017;47(5):418–437. PubMed: 28340309.
   PubMed Web of Science ®Google Scholar
• Guo S, Wang Y, Zhou D, et al. Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging. Sci Rep. 2014;4(1):5959. PubMed: 25091112.
   PubMedGoogle Scholar
• Kurabe N, Hayasaka T, Ogawa M, et al. Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4. Cancer Science. 2013;104(10):1295–1302. PubMed: 23815430.
   PubMed Web of Science ®Google Scholar
• Alexander J, Gildea L, Balog J, et al. A novel methodology for in vivo endoscopic phenotyping of colorectal cancer based on real-time analysis of the mucosal lipidome: a prospective observational study of the iKnife. Surg Endosc. 2017;31(3):1361–1370. PubMed: 27501728.
   PubMed Web of Science ®Google Scholar
• Guo Y, Ren J, Li X, et al. Simultaneous quantification of serum multi-phospholipids as potential biomarkers for differentiating different pathophysiological states of lung, stomach, intestine, and pancreas. J Cancer. 2017;8(12):2191–2204. PubMed: 28819421.
   PubMed Web of Science ®Google Scholar
• Blight EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37(8):911–917. [ PubMed: 13671378].
   PubMedGoogle Scholar
• Stevanovic M, Vekic J, Bogavac-Stanojevic N, et al. Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development. Biochem Med (Zagreb). 2018;28(3):030703. PubMed: 30429670.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao XW, Liu DB, et al. Lipid levels in serum and cancerous tissues of colorectal cancer patients. World J Gastroenterol. 2014;20(26):8646–8652. PubMed: 25024621.
   PubMed Web of Science ®Google Scholar
• Xuan Q, Hu C, Yu D, et al. Development of a high coverage pseudotargeted lipidomics method based on ultra-high performance liquid chromatography-mass spectrometry. Anal Chem. 2018;90(12):7608–7616. PubMed: 29807422.
   PubMed Web of Science ®Google Scholar
• Yang L, Cui X, Zhang N, et al. Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers. Anal Bioanal Chem. 2015;407(17):5065–5077. PubMed: 25651902.
   PubMed Web of Science ®Google Scholar
• Li M, Feng B, Liang Y, et al. Lipid profiling of human plasma from peritoneal dialysis patients using an improved 2D (NP/RP) LC-QToF MS method. Anal Bioanal Chem. 2013;405(21):6629–6638. PubMed: 23774833.
   PubMed Web of Science ®Google Scholar
• Li M, Tong X, Lv P, et al. A not-stop-flow online normal-/reversed-phase two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry method for comprehensive lipid profiling of human plasma from atherosclerosis patients. J Chromatogr A. 2014;1372C:110–119. PubMed: 25465009.
   PubMedGoogle Scholar
• Currie E, Schulze A, Zechner R, et al. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. PubMed: 23791484.
   PubMed Web of Science ®Google Scholar
• Yi M, Li J, Chen S, et al. Emerging role of lipid metabolism alterations in Cancer stem cells. J Exp Clin Cancer Res. 2018;37(1):118. PubMed: 29907133.
   PubMedGoogle Scholar
• Wang H, Xi Q, Wu G. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway. Cancer Medicine. 2016;5(7):1599–1606. PubMed: 27139420.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73(2):377–392. PubMed: 26499846.
   PubMed Web of Science ®Google Scholar
• Qu Q, Zeng F, Liu X, et al. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Dis. 2016;7(5):e2226. PubMed: 27195673.
   PubMedGoogle Scholar
• Dean JM, Lodhi IJ. Structural and functional roles of ether lipids. Protein Cell. 2018;9(2):196–206. PubMed: 28523433.
   PubMed Web of Science ®Google Scholar
• Nagan N, Zoeller RA. Plasmalogens: biosynthesis and functions. Prog Lipid Res 2001;40(3):199–229. [ PubMed: 11275267].
   PubMed Web of Science ®Google Scholar
• Lopez DH, Bestard-Escalas J, Garate J, et al. Tissue-selective alteration of ethanolamine plasmalogen metabolism in dedifferentiated colon mucosa. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863(8):928–938. PubMed: 29709709.
   PubMed Web of Science ®Google Scholar
• Dahabieh MS, Ha Z, Di Pietro E, et al. Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis. Cell Death Differ. 2017;24(11):1912–1924. PubMed: 28731463.
   PubMed Web of Science ®Google Scholar
• Fang Y, Vilella-Bach M, Bachmann R, et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 2001;294(5548):1942–1945. PubMed: 11729323.
   PubMed Web of Science ®Google Scholar
• Foster DA, Salloum D, Menon D, et al. Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR). J Biol Chem. 2014;289(33):22583–22588. PubMed: 24990952.
   PubMed Web of Science ®Google Scholar
• Coviello G, Tutino V, Notarnicola M, et al. Erythrocyte membrane fatty acids profile in colorectal cancer patients: a preliminary study. Anticancer Res. 2014;34(9):4775–4779. PubMed: 25202057.
   PubMed Web of Science ®Google Scholar
• Rodríguez JP, Guijas C, Astudillo AM, et al. Sequestration of 9-Hydroxystearic acid in FAHFA (Fatty Acid Esters of Hydroxy Fatty Acids) as a protective mechanism for colon carcinoma cells to avoid apoptotic cell death. Cancers (Basel). 2019;11(4):524. PubMed: 31013768.
   Web of Science ®Google Scholar
• Pickens CA, Lane-Elliot A, Comstock SS, et al. Altered saturated and monounsaturated plasma phospholipid fatty acid profiles in adult males with colon adenomas. Cancer Epidemiol Biomarkers Prev. 2016;25(3):498–506. PubMed: 26721667.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen H, Li Y, et al. Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. Oncol Rep. 2015;34(1):447–454. PubMed: 25975960.
   PubMed Web of Science ®Google Scholar
• Zhang J1, Zhang L, Ye X, et al. Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. Prostaglandins Leukot Essent Fatty Acids. 2013;88(5):355–360. PubMed: 23465412.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xu H, Liu R, et al. A novel strategy for targeted lipidomics based on LC-Tandem-MS parameters prediction, quantification, and multiple statistical data mining: evaluation of lysophosphatidylcholines as potential cancer biomarkers. Anal Chem. 2019;91(5):3389–3396. PubMed: 30689358.
   PubMed Web of Science ®Google Scholar
• Perttula K, Edmands WM, Grigoryan H, et al. Evaluating ultra-long-chain fatty acids as biomarkers of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2016;25(8):1216–1223. PubMed: 27257090.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Xiao Y, Elson P, et al. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol. 2007;25(19):2696–2701. PubMed: 17602074.
   PubMed Web of Science ®Google Scholar
• Yang K, Li H, Dong J, et al. Expression profile of polyunsaturated fatty acids in colorectal cancer. World J Gastroenterol. 2015;21(8):2405–2412. PubMed: 25741148.
   PubMed Web of Science ®Google Scholar
• Shim YJ, Choi KY, Lee WC, et al. Phospholipid fatty acid patterns in the mucosa of human colorectal adenomas and carcinomas. Nutr Res. 2005;25(3):261–269.
   Web of Science ®Google Scholar
• Lee GB, Lee JC, Moon MH. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Anal Chim Acta. 2019;1063:117–126. [ PubMed: 30967175].
   PubMed Web of Science ®Google Scholar
• de Figueiredo Junior AG, Serafim PVP, de Melo AA, et al. Analysis of the lipid profile in patients with colorectal cancer in advanced stages. Asian Pac J Cancer Prev. 2018;19(5):1287–1293. PubMed: 29802561.
   PubMedGoogle Scholar
• Mirnezami R, Spagou K, Vorkas PA, et al. Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects. Mol Oncol. 2014;8(1):39–49. PubMed: 24112879.
   PubMed Web of Science ®Google Scholar
• Shen S, Yang L, Li L, et al. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer. J Chromatogr B Analyt Technol Biomed Life Sci. PubMed: 29028617 2017;1068-1069: 41–48.
   PubMed Web of Science ®Google Scholar
• Crotti S, Agnoletto E, Cancemi G, et al. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker. Anal Bioanal Chem. 2016;408(23):6321–6328. PubMed: 27379390.
   PubMed Web of Science ®Google Scholar